Apostolia Maria Tsimberidou

The University of Texas MD Anderson Cancer Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 70 Citations 16,245 426 World Ranking 17664 National Ranking 8980

Overview

What are the main themes of her work throughout her whole career to date

In her papers, Apostolia Maria Tsimberidou integrates diverse fields, such as Internal medicine and Intensive care medicine. In her works, she undertakes multidisciplinary study on Intensive care medicine and Internal medicine. Her Biochemistry study frequently draws connections to adjacent fields such as Protein kinase B. She brings together Protein kinase B and Phosphorylation to produce work in her papers. Her Phosphorylation study frequently draws connections to other fields, such as Biochemistry. In her works, she undertakes multidisciplinary study on Cancer and Endometrial cancer. Apostolia Maria Tsimberidou integrates Endometrial cancer and Cancer in her studies. Apostolia Maria Tsimberidou merges Cancer research with Colorectal cancer in her research. In her study, she carries out multidisciplinary Colorectal cancer and Cancer research research.

Apostolia Maria Tsimberidou most often published in these fields:

Internal medicine (100.00%)
Biochemistry (60.00%)
Cancer (60.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

Marilyn M. Li;Michael Datto;Eric J. Duncavage;Shashikant Kulkarni.
The Journal of Molecular Diagnostics (2017)

1228 Citations

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn.
Journal of Clinical Oncology (2018)

680 Citations

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia M. Tsimberidou;Nancy G. Iskander;David S. Hong;Jennifer J. Wheler.
Clinical Cancer Research (2012)

512 Citations

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Filip Janku;Jennifer J. Wheler;Shannon N. Westin;Stacy L. Moulder.
Journal of Clinical Oncology (2012)

482 Citations

PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

Filip Janku;Apostolia Maria Tsimberidou;Ignacio Garrido-Laguna;Xuemei Wang.
Molecular Cancer Therapeutics (2011)

398 Citations

Richter syndrome: biology, incidence, and therapeutic strategies.

Apostolia Maria Tsimberidou;Michael J. Keating.
Cancer (2005)

364 Citations

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

Jordi Rodon;Jean Charles Soria;Raanan Berger;Wilson H. Miller.
Nature Medicine (2019)

292 Citations

Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

Apostolia Maria Tsimberidou;Susan O'Brien;Issa Khouri;Francis J. Giles.
Journal of Clinical Oncology (2006)

287 Citations

PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

Filip Janku;Jennifer J. Wheler;Aung Naing;Gerald S. Falchook.
Cancer Research (2013)

276 Citations

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Qi Liu;Luis Fayad;Fernando Cabanillas;Fredrick B. Hagemeister.
Journal of Clinical Oncology (2006)

274 Citations

If you think any of the details on this page are incorrect, let us know.